VICTOR
NAVAS LOPEZ
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (28)
2024
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity
European Journal of Pediatrics, Vol. 182, Núm. 10, pp. 4633-4645
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
2021
-
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study (European Journal of Pediatrics, (2021), 180, 9, (3029-3038), 10.1007/s00431-021-04063-6)
European Journal of Pediatrics
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
-
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
European Journal of Pediatrics, Vol. 180, Núm. 9, pp. 3029-3038
-
Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease
Pharmaceutics, Vol. 13, Núm. 1, pp. 1-17
2020
-
Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease
International Journal of Molecular Sciences, Vol. 21, Núm. 9
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
-
Predictors of response to exclusive enteral nutrition in newly diagnosed crohn’s disease in children: PRESENCE Study from SEGHNP
Nutrients, Vol. 12, Núm. 4
-
Spanish Pediatric Inflammatory Bowel Disease Diagnostic Delay Registry: SPIDER Study From Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica
Frontiers in Pediatrics, Vol. 8
2014
-
Present; prescripción de nutrición enteral en la enfermedad de crohn pediátrica en españa
Nutricion Hospitalaria, Vol. 29, Núm. 3, pp. 537-546
-
The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25years (1985-2009): The EXPERIENCE registry
Journal of Crohn's and Colitis, Vol. 8, Núm. 8, pp. 763-769
2007
-
Unperforated hymen as an uncommon cause of recurrent abdominal pain [2]
Anales de Pediatria
2006
-
Evaluación de las estrategias terapéuticas en el síndrome nefrótico congénito tipo Finlandés
Anales de Pediatria, Vol. 65, Núm. 6, pp. 561-568
-
Herpes zoster en un paciente con enfermedad de Crohn en tratamiento con azatioprina
Acta Pediatrica Espanola, Vol. 64, Núm. 8, pp. 402-404
-
Nuestra experiencia con la ventilación de alta frecuencia oscilatoria
Anales de Pediatria, Vol. 65, Núm. 1, pp. 67-72